Primary Job Title Member of the Board of Directors Primary Organization 
TetraLogic Pharmaceuticals
Location New York, New York, United States Regions Greater New York Area, East Coast, Northeastern US Gender Male
LinkedIn View on LinkedIn
Michael Kishbauch was President and Chief Executive Officer of Achillion Pharmaceuticals, Inc. from July 2004 until his retirement in September 2013. From September 1996 to July 2004, Michael Kishbauch founded and served as President and Chief Executive Officer of OraPharma, Inc., a commercial-stage pharmaceutical company focused on oral health
care, which was acquired by Johnson & Johnson in 2003.
Prior to OraPharma, Inc., Michael Kishbauch held senior management positions with MedImmune, Inc. Michael Kishbauch currently serves on the Board of Directors of Achillion Pharmaceuticals, Inc. and Progenics Pharmaceuticals, Inc. Michael Kishbauch holds a M.B.A. from the Wharton School of the University of Pennsylvania and a B.A. in biology from Wesleyan University.
